Evidence map›Paper›PMID 39554983›Full record

ArticleJGH open : an open access journal of gastroenterology and hepatology2024

Influence of patient characteristics on

William D Chey, Francis Mégraud, Loren Laine, Neila Smith, Eckhard Leifke, Barbara Hunt, Colin W Howden

Abstract read
In one paragraph

Article in JGH open : an open access journal of gastroenterology and hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

William D CheyGastroenterology and Nutrition Sciences, Division of Gastroenterology and Hepatology, Department of Internal Medicine Michigan Medicine Ann Arbor Michigan USA.ORCID https://orcid.org/0000-0002-4584-4026
Francis MégraudEmeritus, INSERM U1312 University of Bordeaux Bordeaux France.
Loren LaineMedicine (Digestive Diseases) Yale School of Medicine New Haven Connecticut USA.
Neila SmithPhathom Pharmaceuticals, Research and Development Buffalo Grove Illinois USA.
Eckhard LeifkePhathom Pharmaceuticals, Research and Development Buffalo Grove Illinois USA.
Barbara HuntPhathom Pharmaceuticals, Research and Development Buffalo Grove Illinois USA.
Colin W HowdenEmeritus, Department of Medicine University of Tennessee College of Medicine Memphis Tennessee USA.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

The efficacy of vonoprazan-based dual and triple therapy vs. lansoprazole-based triple therapy in the treatment of

Indexed as

clinical trialHelicobacter pyloripotassium competitive acid blockersproton pump inhibitorsvonoprazan

Identifiers

PMID39554983
PMCPMC11567116

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.